Back
RBC U.S. Dividend Covered Call ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
75
RUDC.TO
RBC U.S. Dividend Covered Call ETF
Last Price:
23.08
Seasonality Move:
6.34%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Buy
75
RBC U.S. Dividend Covered Call ETF (RUDC.TO)
is a Buy
Is RBC U.S. Dividend Covered Call ETF a Buy, Sell or Hold?
- The current RBC U.S. Dividend Covered Call ETF [RUDC.TO] share price is $23.08. The Score for RUDC.TO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- RUDC.TO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RUDC.TO Stock Price Chart
What is RBC U.S. Dividend Covered Call ETF's stock price today?
-
The RBC U.S. Dividend Covered Call ETF share price today is $23.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RUDC.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RUDC.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 65.24 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.55 - 23.07) | Buy |
Bollinger Bands (100): | (21.7 - 22.66) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.32 | Buy |
Relative Strength Index (14 RSI): | 81.62 | Buy |
Chaikin Money Flow: | 315379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 26.46) | Buy |
Bollinger Bands (100): | (7.85 - 19.03) | Buy |
RUDC.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.04 | Buy |
20-day SMA: | 22.9 | Buy |
50-day SMA: | 22.55 | Buy |
200-day SMA: | 21.71 | Buy |
8-day EMA: | 23.03 | Buy |
20-day EMA: | 22.89 | Buy |
50-day EMA: | 22.6 | Buy |
200-day EMA: | 21.76 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.35 | Buy |
20-day SMA: | 22.81 | Buy |
50-day SMA: | 14.24 | Buy |
200-day SMA: | 15.81 | Buy |
8-day EMA: | 27.13 | Buy |
20-day EMA: | 22.88 | Buy |
50-day EMA: | 17.49 | Buy |
200-day EMA: | 15.94 | Buy |
RBC U.S. Dividend Covered Call ETF Earnings Growth & RUDC.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
RBC U.S. Dividend Covered Call ETF Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |